A preventive health checkup is often described as prevention itself. It is more accurate to describe it as the diagnostic step in a longer preventive process.
Blood pressure readings, cholesterol panels, glucose measurements, and risk questionnaires can identify what deserves attention. They do not, on their own, reduce the risk they uncover.
That gap is not simply a matter of patient motivation or clinician diligence. It is a design problem in what happens after the appointment ends.
A checkup identifies the starting point. Prevention depends on what follows.
The evidence is not the problem
In 2001, Phillips and colleagues published a landmark paper in Annals of Internal Medicine describing clinical inertia: the failure to initiate or intensify treatment when doing so is clinically indicated.
The authors identified several contributing factors, including overestimating the care already being delivered, relying on “soft” reasons to delay intensification, and the absence of systems that reliably prompt the next step.
The concept is most directly applied to treatment decisions for established clinical conditions. The broader structural lesson also matters for prevention: identifying an actionable risk factor does not guarantee that a defined intervention, follow-up appointment, or monitoring process will follow.
This is not a criticism of any one clinician. It describes what tends to happen when busy healthcare settings depend on memory, individual initiative, and future appointments to close every preventive-care loop.
A documented risk factor is not the same as a managed risk factor.
The evidence is not the bottleneck. The follow-through infrastructure is.
Risk calculators got the question right
Cardiovascular risk calculators have been among the most important attempts to make preventive findings more actionable.
Tools such as the Framingham Risk Score and the ACC/AHA Pooled Cohort Equations combine several risk factors into an estimate of a person’s probability of experiencing a cardiovascular event over a defined period. They gave clinicians and patients a shared number around which to discuss prevention.
That was an important advance. Risk is easier to discuss when it is made visible. But a gap persists between quantifying risk and modifying it.
A calculator can estimate how factors such as age, blood pressure, cholesterol, diabetes, and smoking contribute to current risk. It cannot deliver an exercise plan, support behaviour change, verify whether activity occurred, adjust medication, or ensure that a borderline result is reassessed.
Producing a risk percentage is not the same as managing the modification of that risk over time.
Risk calculators identified the question correctly and gave preventive care a shared vocabulary. The infrastructure needed to act on the answer after the appointment is still being built.
A working model—and its limits
If risk calculators represent the diagnostic aspiration, the Kaiser Permanente Northern California hypertension program represents a proof of concept for systematic follow-through.
The program combined a population-wide hypertension registry, evidence-based treatment protocols, regular measurement, performance feedback, medical-assistant visits, and standardized approaches to treatment intensification.
Between 2001 and 2009, blood pressure control in the eligible population increased from 43.6% to 80.4%, exceeding concurrent state and national control rates.
The lesson was not that one intervention or one clinician solved hypertension. The program created an operating system around a recognized risk factor. Patients were identified, remained visible, and were connected to repeat measurement and defined next steps.
The model also depended on the infrastructure of a large, integrated health system with a population registry and coordinated clinical workflows. Many people receive preventive screening through fragmented encounters, different providers, walk-in settings, employer programs, or periodic checkups. Their results may be accurate without entering a continuous process that follows the risk factor between visits.
This is the limit of screening as a standalone strategy. Detection can occur in a moment. Risk modification requires continuity.
The nuance: clinical inertia does not look the same for every patient
A checkup result and a follow-up plan are not automatically connected, even when the result is documented correctly.
Consider two patients who attend the same clinic and receive similar borderline-elevated blood pressure and cholesterol results.
The first patient is advised to exercise, improve nutrition, and arrange another measurement in several months. No follow-up is scheduled, and there is no mechanism for the clinical team to see what happens between visits.
The second patient receives the same appropriate clinical advice but is also enrolled in a physician-supported exercise pathway using My Heart Fitness. Reported exercise is translated into MET-minutes, activity is followed over time, and summary reports can make progress—or the absence of progress—more visible to the patient and clinician.
The second pathway does not guarantee that the patient’s blood pressure or cholesterol will improve. It does create a way to determine whether the recommended behaviour is occurring and whether another conversation or clinical reassessment may be needed.
Both patients received an accurate assessment. Only one has a defined mechanism connecting the recommendation to longitudinal visibility.
This is the gap that neither a single checkup nor a risk score fully occupies: the space between identifying risk and managing it, between a data point and a maintained preventive trajectory.
What closing the gap requires
Making a preventive health checkup clinically meaningful—not simply clinically accurate—requires four elements.
- Automatic follow-up triggers. An abnormal or borderline finding should lead to a defined next step rather than relying solely on the patient or clinician to remember it months later. The trigger may be a repeat measurement, scheduled appointment, referral, or structured behavioural intervention.
- Defined care pathways. Findings should map to appropriate responses based on severity, clinical context, and guidelines. This does not mean every person receives the same intervention. It means the pathway from finding to action is explicit.
- Between-visit measurement and engagement. Prevention unfolds between appointments. A meaningful model needs a way to follow relevant behaviours or risk factors during that interval rather than waiting until the next annual checkup to discover what happened.
- Data continuity and accountability. A risk factor identified once should remain visible to the person and the professionals coordinating their care. Someone—or some defined workflow—must be responsible for recognizing when the expected follow-up has not occurred.
None of these requirements are technologically impossible. They are operationally underdeveloped.
Where My Heart Fitness fits after the checkup
My Heart Fitness was created to help make exercise—one of the most frequently recommended preventive behaviours—more visible after the clinical encounter ends.
The platform helps translate patient-reported exercise into MET-minutes, allowing different activities to contribute to a common weekly measure. It then tracks those reported activities over time so patients can see whether they are building a consistent exercise trajectory rather than relying on a general impression that they have been “more active.”
In physician-supported settings, My Heart Fitness can generate patient and physician reports that summarize reported exercise behaviour. This provides a more specific basis for follow-up conversations about activity volume, consistency, barriers, and progression.
My Heart Fitness does not replace a preventive health checkup, diagnose cardiovascular disease, determine medication treatment, or substitute for clinical decision-making. A blood pressure reading still needs to be interpreted as a blood pressure reading. A cholesterol result still requires clinical assessment.
Its role is to help close one part of the post-checkup gap: making the exercise that happens—or does not happen—between visits easier to see and follow.
A preventive recommendation becomes more useful when it remains visible after the appointment.
Why this moment matters
Two converging forces are creating an unusual window for progress.
First, on June 10, 2026, the Government of Canada launched the National Advisory Committee on Preventive Health Services. The committee replaces the previous Canadian Task Force on Preventive Health Care and has been given a mandate to develop evidence-based, person- and equity-centred preventive health guidelines for primary care.
That strengthens the front end of prevention: deciding what should be screened, assessed, or recommended.
Second, wearable devices and remote-monitoring technologies can increasingly capture behavioural and physiological information outside the clinic. A 2026 European Heart Journal review described their potential for longitudinal cardiovascular assessment while also identifying the unresolved barriers: inconsistent measures, limited electronic-record integration, and a lack of standardized clinical workflows for interpreting and acting on the data.
That creates an important distinction. More guidance tells healthcare what should happen. More data shows what may be happening. Neither automatically creates a functioning pathway between the two.
The missing piece is the operational architecture connecting a finding at a preventive checkup to a behaviour or treatment plan that remains visible afterward.
That is the role My Heart Fitness is working to support for exercise: helping turn a preventive recommendation into a measurable trajectory that patients and clinicians can follow over time.
Frequently asked questions
What does a preventive health checkup actually do?
A preventive checkup can identify modifiable risk factors such as elevated blood pressure, cholesterol, glucose, smoking, physical inactivity, and other findings relevant to a person’s age and health history. It identifies where attention may be needed, but the checkup itself does not deliver the ongoing intervention required to reduce that risk.
Why does a cardiovascular risk score not lower someone’s risk?
A risk score estimates current or future cardiovascular risk using information available at that time. Reducing the risk requires a separate process, which may include medication, exercise, nutrition changes, smoking cessation, repeat testing, or management of underlying conditions.
What is clinical inertia?
Clinical inertia traditionally refers to the failure to initiate or intensify treatment when treatment is clinically indicated. It is influenced by clinician, patient, and health-system factors and helps explain why recognizing a problem does not always lead automatically to a change in care.
What should happen after a risk factor is identified?
The appropriate response depends on the finding and the person’s overall clinical context. It may include confirmation with repeat testing, a defined behavioural or medication plan, scheduled follow-up, referral, or more urgent evaluation.
How does My Heart Fitness support preventive follow-up?
My Heart Fitness helps patients record exercise and translates reported activity into MET-minutes so that progress can be followed over time. In physician-supported care, summary reports can make that exercise behaviour more visible during follow-up conversations.
How often should adults receive preventive screening?
Screening intervals vary by age, medical history, family history, existing risk factors, and the specific test involved. A primary care provider can determine which screenings are appropriate and how often they should occur.
References
- Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–834.
- Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310(7):699–705.
- Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. Circulation. 2014;129(25 Suppl 2):S49–S73.
- Hughes AM, Taylor DJ, Morris PD, Brittain EL. Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease prevention. Eur Heart J. 2026;47(18):2130–2145.
- Public Health Agency of Canada. New National Advisory Committee to support preventive health care in Canada. Ottawa: Government of Canada; June 10, 2026.
Educational disclaimer: This article is intended for general educational purposes and does not constitute medical advice. Consult a healthcare provider regarding personal risk factors, screening schedules, and treatment decisions.